Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

  • K. D. Lewis
  • , K. Peris
  • , A. Sekulic
  • , A. J. Stratigos
  • , L. Dunn
  • , Z. Eroglu
  • , A. L.S. Chang
  • , M. R. Migden
  • , S. Y. Yoo
  • , K. Mohan
  • , E. Coates
  • , E. Okoye
  • , T. Bowler
  • , J. F. Baurain
  • , O. Bechter
  • , A. Hauschild
  • , M. O. Butler
  • , L. Hernandez-Aya
  • , L. Licitra
  • , R. I. Neves
    • E. S. Ruiz, F. Seebach, I. Lowy, P. Goncalves, M. G. Fury

Research output: Contribution to journal › Article › peer-review

29   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science